Diffusion Pharmaceuticals Stock Current Valuation
| DFFNDelisted Stock | USD 3.27 0.17 5.48% |
Valuation analysis of Diffusion Pharmaceuticals helps investors to measure Diffusion Pharmaceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Diffusion Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Diffusion Pharmaceuticals is based on 3 months time horizon. Increasing Diffusion Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Diffusion Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Diffusion Stock. However, Diffusion Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.27 | Real 2.89 | Hype 3.27 | Naive 3.42 |
The intrinsic value of Diffusion Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Diffusion Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Diffusion Pharmaceuticals helps investors to forecast how Diffusion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Diffusion Pharmaceuticals more accurately as focusing exclusively on Diffusion Pharmaceuticals' fundamentals will not take into account other important factors: Diffusion Pharmaceuticals Company Current Valuation Analysis
Diffusion Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Diffusion Pharmaceuticals Current Valuation | (6.02 M) |
Most of Diffusion Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Diffusion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Diffusion Pharmaceuticals has a Current Valuation of (6.02 Million). This is 100.04% lower than that of the Biotechnology sector and 100.13% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.04% higher than that of the company.
Diffusion Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Diffusion Pharmaceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Diffusion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Diffusion Pharmaceuticals by comparing valuation metrics of similar companies.Diffusion Pharmaceuticals is currently under evaluation in current valuation category among its peers.
Diffusion Fundamentals
| Return On Equity | -0.64 | |||
| Return On Asset | -0.38 | |||
| Current Valuation | (6.02 M) | |||
| Shares Outstanding | 2.04 M | |||
| Shares Owned By Insiders | 0.23 % | |||
| Shares Owned By Institutions | 10.27 % | |||
| Number Of Shares Shorted | 2.54 K | |||
| Price To Earning | (0.60) X | |||
| Price To Book | 0.51 X | |||
| EBITDA | (15.97 M) | |||
| Net Income | (15.59 M) | |||
| Cash And Equivalents | 25.86 M | |||
| Cash Per Share | 12.68 X | |||
| Total Debt | 67.89 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 11.59 X | |||
| Book Value Per Share | 6.97 X | |||
| Cash Flow From Operations | (14.97 M) | |||
| Short Ratio | 0.29 X | |||
| Earnings Per Share | (7.11) X | |||
| Target Price | 40.0 | |||
| Number Of Employees | 13 | |||
| Beta | 1.76 | |||
| Market Capitalization | 8.98 M | |||
| Total Asset | 22.64 M | |||
| Retained Earnings | (145.6 M) | |||
| Working Capital | 20.22 M | |||
| Current Asset | 3.29 M | |||
| Current Liabilities | 3.68 M | |||
| Z Score | 69.08 | |||
| Net Asset | 22.64 M |
About Diffusion Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Diffusion Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Diffusion Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Diffusion Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Diffusion Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diffusion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Diffusion Stock
| 0.81 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.71 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.69 | BKRKF | PT Bank Rakyat | PairCorr |
Moving against Diffusion Stock
| 0.88 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.82 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.81 | WMT | Walmart Aggressive Push | PairCorr |
| 0.79 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.77 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
The ability to find closely correlated positions to Diffusion Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diffusion Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diffusion Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diffusion Pharmaceuticals to buy it.
The correlation of Diffusion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diffusion Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diffusion Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diffusion Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Diffusion Stock
If you are still planning to invest in Diffusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diffusion Pharmaceuticals' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |